MENU

Articles for Indivior (LSE: INDV)

Are these the cheapest growth stocks in the FTSE 250?

Should you buy, sell or hold these two FTSE 250 (INDEXFTSE: MCX) growth stocks? More »

Why the Indivior share price could be a FTSE 250 buy after today’s 30% fall

Roland Head looks at the numbers behind today's profit warning from FTSE 250 (INDEXFTSE:MCX) pharma stock Indivior plc (LON:INDV). More »

2 growth champions I’d buy and hold for two decades

These companies have room to expand rapidly over the next 20 years. More »

2 FTSE 250 pharma stocks I’d buy today and hold for another five years

Roland Head takes a look at two unusual pharma stocks with long-term growth potential. More »

2 stocks I’d invest £1,000 in right now

If you are looking for decent share ideas, check out these two that reported on Thursday. More »

2 no-brainer stocks I’d buy in pharma

Royston Wild reveals two pharma stocks with the capability to deliver knockout profits growth. More »

2 monster stocks in the making I’d buy today

These two shares could post high total returns. More »

2 growth stocks I’d buy and hold for 2018

Roland Head takes a look at two promising growth stocks from his watch list. More »

2 soaring growth stocks I’d consider buying today

These two stocks have grown strongly in recent years and Harvey Jones expects further progress. More »

Why this beaten-up FTSE 100 dividend stock could be a bargain

Roland Head explains why he'd buy this 6% yielder from the FTSE 100 (INDEXFTSE:UKX). More »

Why I think Indivior plc is a growth stock for shrewd investors

You shouldn't count out Indivior plc (LSE: INDV) just yet. More »

Why I’d avoid Indivior plc today after shares crash 35%

Indivior plc (LON: INDV) is one of today's major fallers. More »

This great value stock is a better bet than Sirius Minerals plc

Royston Wild looks at a stock with more investment appeal than Sirius Minerals plc (LON: SXX). More »

2 value stocks to consider in an expensive market: Indivior plc and Impellam Group plc

Should you buy Indivior plc (LON:INDV) and Impellam Group plc (LON:IPEL) as value plays following today's announcements? More »

These 2 FTSE 250 flyers are up 60% in just 12 months

Investors in these two FTSE 250 (INDEXFTSE:MCX) companies have plenty to celebrate, says Harvey Jones. More »

2 top value stocks you should consider buying right now

Royston Wild runs the rule over two white-hot bargain stocks. More »

Will this spin-off stock continue to slay FTSE 100 giants?

Roland Head asks if this potential FTSE 100 (INDEXFTSE:UKX) giant killer is worth the risk. More »

2 fast-growing FTSE 250 stocks for a prosperous 2017

It could pay to take a closer look at these surprise winners, says Roland Head. More »

Why AstraZeneca plc may still not be cheap enough to beat this upstart

Roland Head takes a look at the latest figures from AstraZeneca plc (LON:AZN) and considers a potential alternative. More »

The Good, the Bad and the Ugly of pharma stocks

Bilaal Mohamed reveals his best and worst picks from the pharmaceuticals sector. More »